Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

NCT07036133

Conditions
Advanced Solid Tumors, Hematologic Diseases, Hematologic Malignancies, +4 more
Locations
  • TOI Clinical Research Cerritos, California, United States
  • Northwestern University - Feinberg School of Medicine Chicago, Illinois, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Gabrail Cancer Center Canton, Ohio, United States
View Trial Details
Recruiting

This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.

NCT06756451

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations
  • The First Affiliated Hospital of USTC Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
View all 16 locations
View Trial Details

Related conditions